| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BDMDBaird Medical Investment Holdings Limited | 45.91M | 1.25 | 2.55 | 17.74% | 33.62% | 33% | 0.53 | |
| IVFINVO Fertility, Inc. | 12.29M | 0.81 | -0.03 | 116.25% | -417.01% | -495.09% | 0.78 | |
| AEMDAethlon Medical, Inc. | 2.64M | 2.71 | -0.03 | -0.2% | 0.13 | |||
| HYPDHyperion DeFi, Inc. | 27.38M | 3.35 | -0.06 | 14.14% | -73.86% | -36.05% | ||
| NAOVNanoVibronix, Inc. | 1.59M | 1.46 | -0.11 | 12.05% | -133.04% | -8.41% | 0.19 | |
| ALURAllurion Technologies Inc. | 23.21M | 1.89 | -0.16 | -39.94% | -251.56% | |||
| RBOTVicarious Surgical Inc. | 18.48M | 2.86 | -0.27 | -380.42% | 0.30 | |||
| TELATELA Bio, Inc. | 44.09M | 0.99 | -0.74 | 18.56% | -50.61% | -25.05% | 1.51 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 24.39M | 30.53M | 26.38M | 34.46M | 35.36M | 42.16M | 53.49M |
| Revenue Growth % | - | 0.25% | -0.14% | 0.31% | 0.03% | 0.19% | 0.27% |
| Cost of Goods Sold | 14.78M | 17.3M | 12.31M | 16.63M | 15.4M | 21.06M | 27.64M |
| COGS % of Revenue | 0.61% | 0.57% | 0.47% | 0.48% | 0.44% | 0.5% | 0.52% |
| Gross Profit | 9.61M | 13.23M | 14.07M | 17.83M | 19.95M | 21.11M | 25.85M |
| Gross Margin % | 0.39% | 0.43% | 0.53% | 0.52% | 0.56% | 0.5% | 0.48% |
| Gross Profit Growth % | - | 0.38% | 0.06% | 0.27% | 0.12% | 0.06% | 0.22% |
| Operating Expenses | 18.93M | 25.94M | 32.58M | 37.48M | 40.13M | 33.34M | 36.52M |
| OpEx % of Revenue | 0.78% | 0.85% | 1.23% | 1.09% | 1.14% | 0.79% | 0.68% |
| Selling, General & Admin | 16.14M | 17.15M | 23.77M | 23.89M | 27.17M | 26.1M | 26.49M |
| SG&A % of Revenue | 0.66% | 0.56% | 0.9% | 0.69% | 0.77% | 0.62% | 0.5% |
| Research & Development | 2.78M | 7.57M | 7.55M | 12.36M | 11.81M | 6.14M | 5.33M |
| R&D % of Revenue | 0.11% | 0.25% | 0.29% | 0.36% | 0.33% | 0.15% | 0.1% |
| Other Operating Expenses | 0 | 1.23M | 1.26M | 1.24M | 1.15M | 1.1M | 4.7M |
| Operating Income | -9.32M | -12.71M | -18.5M | -19.65M | -20.18M | -12.23M | -10.66M |
| Operating Margin % | -0.38% | -0.42% | -0.7% | -0.57% | -0.57% | -0.29% | -0.2% |
| Operating Income Growth % | - | -0.36% | -0.46% | -0.06% | -0.03% | 0.39% | 0.13% |
| EBITDA | -4.73M | -8.85M | -15.43M | -16.89M | -16.77M | -8.71M | -6.73M |
| EBITDA Margin % | -0.19% | -0.29% | -0.58% | -0.49% | -0.47% | -0.21% | -0.13% |
| EBITDA Growth % | - | -0.87% | -0.74% | -0.09% | 0.01% | 0.48% | 0.23% |
| D&A (Non-Cash Add-back) | 4.59M | 3.87M | 3.07M | 2.76M | 3.41M | 3.52M | 3.93M |
| EBIT | -9.25M | -12.66M | -18.43M | -19.65M | -20.18M | -12.23M | -6.94M |
| Net Interest Income | 0 | -2M | -1.34M | 34K | 17K | 85K | 103K |
| Interest Income | 3.27M | 0 | 0 | 34K | 17K | 85K | 103K |
| Interest Expense | 0 | 2M | 1.34M | 0 | 0 | 0 | 0 |
| Other Income/Expense | -3.26M | -1.94M | -1.27M | 51K | 263K | -2.15M | -20.74M |
| Pretax Income | -12.57M | -14.66M | -19.77M | -19.6M | -19.91M | -14.38M | -31.4M |
| Pretax Margin % | -0.52% | -0.48% | -0.75% | -0.57% | -0.56% | -0.34% | -0.59% |
| Income Tax | 20K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -12.59M | -14.66M | -19.77M | -19.6M | -19.91M | -14.38M | -31.4M |
| Net Margin % | -0.52% | -0.48% | -0.75% | -0.57% | -0.56% | -0.34% | -0.59% |
| Net Income Growth % | - | -0.16% | -0.35% | 0.01% | -0.02% | 0.28% | -1.18% |
| Net Income (Continuing) | -12.59M | -14.66M | -19.77M | -19.6M | -19.91M | -14.38M | -31.4M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -11.77 | -1.57 | -1.81 | -2.10 | -1.96 | -1.31 | -2.73 |
| EPS Growth % | - | 0.87% | -0.15% | -0.16% | 0.07% | 0.33% | -1.08% |
| EPS (Basic) | -11.77 | -1.57 | -1.81 | -2.10 | -1.96 | -1.31 | -2.73 |
| Diluted Shares Outstanding | 1.07M | 10.64M | 10.93M | 9.37M | 10.16M | 10.97M | 11.52M |
| Basic Shares Outstanding | 1.07M | 10.64M | 10.93M | 9.37M | 10.16M | 10.97M | 11.52M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 11.75M | 17.18M | 58.38M | 44.81M | 33.72M | 46.44M | 41.98M |
| Cash & Short-Term Investments | 3.34M | 4.62M | 40.6M | 31.64M | 14.67M | 24.06M | 22.45M |
| Cash Only | 3.34M | 4.62M | 40.6M | 31.64M | 14.67M | 20.62M | 16.26M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 3.44M | 6.19M |
| Accounts Receivable | 3.3M | 3.89M | 2.46M | 4.99M | 6.24M | 4.32M | 6.48M |
| Days Sales Outstanding | 49.42 | 46.46 | 33.98 | 52.83 | 64.42 | 37.43 | 44.21 |
| Inventory | 4.06M | 8.06M | 13.47M | 6.49M | 11.74M | 15.69M | 11.43M |
| Days Inventory Outstanding | 100.33 | 170.15 | 399.58 | 142.43 | 278.2 | 271.95 | 150.9 |
| Other Current Assets | 472K | 0 | 0 | 0 | 1.06M | 2.37M | 1.62M |
| Total Non-Current Assets | 17.14M | 17.35M | 20.73M | 21.65M | 22.13M | 23.14M | 24.32M |
| Property, Plant & Equipment | 3.62M | 2.15M | 4.42M | 7.45M | 6.88M | 10.28M | 664K |
| Fixed Asset Turnover | 6.74x | 14.19x | 5.98x | 4.63x | 5.14x | 4.10x | 80.56x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 12.29M | 13.37M | 12.11M | 10.87M | 12.12M | 11.03M | 6.11M |
| Long-Term Investments | 753K | 0 | 0 | 0 | 442K | 492K | 1.16M |
| Other Non-Current Assets | 476K | 1.84M | 4.21M | 3.34M | 3.13M | 1.34M | 16.38M |
| Total Assets | 28.89M | 34.54M | 79.12M | 66.47M | 55.84M | 69.58M | 66.3M |
| Asset Turnover | 0.84x | 0.88x | 0.33x | 0.52x | 0.63x | 0.61x | 0.81x |
| Asset Growth % | - | 0.2% | 1.29% | -0.16% | -0.16% | 0.25% | -0.05% |
| Total Current Liabilities | 7.66M | 7.83M | 8.47M | 8.71M | 11.42M | 11.63M | 15M |
| Accounts Payable | 1.41M | 1.58M | 2.48M | 2.69M | 5.42M | 4.01M | 6M |
| Days Payables Outstanding | 34.88 | 33.27 | 73.58 | 59.14 | 128.48 | 69.46 | 79.16 |
| Short-Term Debt | 653K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 871K | 777K | 923K | 904K | 768K | 1000K | 1000K |
| Other Current Liabilities | 1.98M | 4.67M | 2.97M | 3.38M | 3.52M | 4.01M | 5M |
| Current Ratio | 1.53x | 2.19x | 6.90x | 5.14x | 2.95x | 3.99x | 2.80x |
| Quick Ratio | 1.00x | 1.16x | 5.30x | 4.40x | 1.92x | 2.64x | 2.04x |
| Cash Conversion Cycle | 114.88 | 183.33 | 359.98 | 136.13 | 214.13 | 239.93 | 115.95 |
| Total Non-Current Liabilities | 41.69M | 57.26M | 3.44M | 2.87M | 2.44M | 10.78M | 32.65M |
| Long-Term Debt | 41.21M | 20.2M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 333K | 3.31M | 2.8M | 2.27M | 1.75M | 2.09M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 479K | 36.73M | 129K | 69K | 167K | 9.03M | 30.56M |
| Total Liabilities | 49.35M | 65.09M | 11.91M | 11.59M | 13.86M | 22.41M | 47.65M |
| Total Debt | 41.21M | 20.53M | 3.81M | 3.31M | 2.8M | 2.31M | 2.61M |
| Net Debt | 37.87M | 15.92M | -36.79M | -28.32M | -11.87M | -18.31M | -13.65M |
| Debt / Equity | - | - | 0.06x | 0.06x | 0.07x | 0.05x | 0.14x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | - | -6.35x | -13.81x | - | - | - | - |
| Total Equity | -20.46M | -30.55M | 67.21M | 54.88M | 41.98M | 47.18M | 18.65M |
| Equity Growth % | - | -0.49% | 3.2% | -0.18% | -0.23% | 0.12% | -0.6% |
| Book Value per Share | -19.13 | -2.87 | 6.15 | 5.85 | 4.13 | 4.30 | 1.62 |
| Total Shareholders' Equity | -20.46M | -30.55M | 67.21M | 54.88M | 41.98M | 47.18M | 18.65M |
| Common Stock | 96K | 11K | 109K | 110K | 111K | 113K | 116K |
| Retained Earnings | -23.53M | -38.19M | -57.99M | -77.59M | -97.51M | -111.89M | -143.29M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -23.53M | 0 | 0 | 0 | 0 | 4K | 6K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -1.89M | -12.59M | -13.79M | -8.97M | -14.86M | -9.66M | -2.27M |
| Operating CF Margin % | -0.08% | -0.41% | -0.52% | -0.26% | -0.42% | -0.23% | -0.04% |
| Operating CF Growth % | - | -5.68% | -0.1% | 0.35% | -0.66% | 0.35% | 0.76% |
| Net Income | -12.59M | -14.66M | -19.77M | -19.6M | -19.91M | -14.38M | -31.4M |
| Depreciation & Amortization | 4.59M | 3.87M | 2.56M | 2.76M | 3.41M | 3.52M | 3.93M |
| Stock-Based Compensation | 1.32M | 102K | 9.04M | 6.87M | 6.61M | 5.54M | 2.67M |
| Deferred Taxes | 0 | -78K | 57K | 527K | 0 | 0 | 0 |
| Other Non-Cash Items | 9.15M | 537K | 505K | 517K | 618K | 3.45M | 25.58M |
| Working Capital Changes | 5.92M | -2.36M | -6.19M | -42K | -5.58M | -7.78M | -3.04M |
| Change in Receivables | 443K | 14K | 1.33M | -2.65M | -1.44M | 1.08M | -2.1M |
| Change in Inventory | -876K | -4.77M | -8.7M | 2.33M | -6.89M | -7.46M | -4.9M |
| Change in Payables | 663K | 127K | 910K | 213K | 2.73M | -1.42M | 1.96M |
| Cash from Investing | -3.89M | -2.09M | -326K | -354K | -115K | -4.16M | -2.16M |
| Capital Expenditures | -3.25M | -2.09M | -366K | -354K | -115K | -236K | -156K |
| CapEx % of Revenue | 0.13% | 0.07% | 0.01% | 0.01% | 0% | 0.01% | 0% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | -644K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 6.96M | 15.95M | 50M | 361K | -1.99M | 19.76M | 78K |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | -198K | -31K | -1.86M | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | -214K | -1.07M | 0 | 0 | -2.4M | 5.88M | 20K |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | -5.13M | -14.68M | -14.16M | -9.32M | -14.97M | -9.89M | -2.43M |
| FCF Margin % | -0.21% | -0.48% | -0.54% | -0.27% | -0.42% | -0.23% | -0.05% |
| FCF Growth % | - | -1.86% | 0.04% | 0.34% | -0.61% | 0.34% | 0.75% |
| FCF per Share | -4.80 | -1.38 | -1.29 | -0.99 | -1.47 | -0.90 | -0.21 |
| FCF Conversion (FCF/Net Income) | 0.15x | 0.86x | 0.70x | 0.46x | 0.75x | 0.67x | 0.07x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 19K | 3K | 18K | 24K |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -107.89% | -32.11% | -41.12% | -32.26% | -95.42% |
| Return on Invested Capital (ROIC) | -40.15% | -689.23% | -175.84% | -51.74% | -53.41% | -31.1% | -47.24% |
| Gross Margin | 39.41% | 43.33% | 53.35% | 51.75% | 56.44% | 50.06% | 48.33% |
| Net Margin | -51.64% | -48.01% | -74.95% | -56.88% | -56.32% | -34.11% | -58.71% |
| Debt / Equity | - | - | 0.06x | 0.06x | 0.07x | 0.05x | 0.14x |
| Interest Coverage | - | -6.35x | -13.81x | - | - | - | - |
| FCF Conversion | 0.15x | 0.86x | 0.70x | 0.46x | 0.75x | 0.67x | 0.07x |
| Revenue Growth | - | 25.18% | -13.58% | 30.62% | 2.61% | 19.25% | 26.87% |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Product | 19.83M | 26.25M | 25.96M | 31.64M | 41.06M |
| Product Growth | - | 32.35% | -1.09% | 21.90% | 29.78% |
| Service | 2.95M | 3.25M | 3.48M | 4.07M | 4.9M |
| Service Growth | - | 10.07% | 7.30% | 16.91% | 20.23% |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| UNITED STATES | 11.6M | 15M | 18.78M | 25.26M | 28.91M |
| UNITED STATES Growth | - | 29.30% | 25.14% | 34.54% | 14.43% |
| Europe | 3.59M | 5.8M | 4.41M | 5.58M | 10.16M |
| Europe Growth | - | 61.79% | -24.05% | 26.67% | 81.86% |
| Asia Excluding South Korea | 4.19M | 3.85M | 3.58M | 3.84M | 5.49M |
| Asia Excluding South Korea Growth | - | -8.06% | -7.24% | 7.27% | 43.04% |
| KOREA, REPUBLIC OF | 3.08M | 4.38M | 2.18M | 257K | 848K |
| KOREA, REPUBLIC OF Growth | - | 42.35% | -50.23% | -88.21% | 229.96% |
| Other Geographical Region | 319K | 449K | 502K | 776K | 563K |
| Other Geographical Region Growth | - | 40.75% | 11.80% | 54.58% | -27.45% |
LENSAR, Inc. (LNSR) reported $59.1M in revenue for fiscal year 2024. This represents a 143% increase from $24.4M in 2018.
LENSAR, Inc. (LNSR) grew revenue by 26.9% over the past year. This is strong growth.
LENSAR, Inc. (LNSR) reported a net loss of $51.5M for fiscal year 2024.
LENSAR, Inc. (LNSR) has a return on equity (ROE) of -95.4%. Negative ROE indicates the company is unprofitable.
LENSAR, Inc. (LNSR) had negative free cash flow of $11.9M in fiscal year 2024, likely due to heavy capital investments.